Hide AAs |
Bloc 1 | Hours (*) | Term | Credits | Weight. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires | | | | | | | | | |
| | | | | | | | | | |
| | UM-B1-PHARMA-016-M Biologie générale humaine | 60 | 8 | 0 | 0 | 30 | 98 | Q1 | 8 | 8 |
| | | M-BHTO-101 - General and Human Biology | | | | | | | | | |
| | | M-CPFA-001 - Remédiation disciplinaire en Biologie 1 | | | | | | | | | |
| | UM-B1-PHARMA-011-M General Chemistry | 46 | 35 | 0 | 0 | 20 | 101 | Q1 | 6 | 6 |
| | | M-CGOB-117 - General Chemistry I | | | | | | | | | |
| | | M-CGOB-112 - Introduction to General Chemistry | | | | | | | | | |
| | | M-CPFA-002 - Remédiation disciplinaire en Chimie générale I (Q1) | | | | | | | | | |
| | UM-B1-PHARMA-012-M Organic Chemistry I | 20 | 19 | 0 | 0 | 20 | 59 | Q1 | 4 | 4 |
| | | M-CGOB-120 - Organic Chemistry I | | | | | | | | | |
| | | M-CPFA-012 - Remédiation disciplinaire en Chimie organique I (Q1) | | | | | | | | | |
| | UM-B1-PHARMA-003-M Mathematical Introduction to Life Sciences | 24 | 24 | 0 | 0 | 30 | 78 | Q1 | 3 | 3 |
| | | S-BIOG-410 - Math. intro to life sciences | | | | | | | | | |
| | UM-B1-PHARMA-015-M Statistiques I | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-051 - Statistiques I | | | | | | | | | |
| | UM-B1-PHARMA-020-M Physique biomédicale | 98 | 78 | 0 | 0 | 50 | 226 | Q1,Q2 | 13 | 13 |
| | | M-PEBI-101 - Introduction to Physics | | | | | | | | | |
| | | M-PEBI-102 - Biomedical Physics I | | | | | | | | | |
| | | M-PEBI-110 - Travaux pratiques de physique biomédicale I | | | | | | | | | |
| | | M-PEBI-105 - Biomedical Physics II | | | | | | | | | |
| | | M-PEBI-111 - Travaux pratiques de physique biomédicale II | | | | | | | | | |
| | | M-CPFA-003 - Remédiation disciplinaire aux cours introductifs en physique | | | | | | | | | |
| | | M-CPFA-013 - Remédiation disciplinaire en Physique biomédicale II | | | | | | | | | |
| | | M-CPFA-020 - Remédiation disciplinaire en physique biomédicale I (partie 1) | | | | | | | | | |
| | | M-CPFA-019 - Remédiation disciplinaire en Physique biomédicale I (partie 2) | | | | | | | | | |
| | UM-B1-PHARMA-013-M General Chemistry II | 30 | 28 | 0 | 0 | 0 | 58 | Q2 | 5 | 5 |
| | | M-CGOB-113 - General Chemistry II | | | | | | | | | |
| | UM-B1-PHARMA-014-M Organic Chemistry II | 15 | 14 | 0 | 0 | 0 | 29 | Q2 | 3 | 3 |
| | | M-CGOB-116 - Organic Chemistry II | | | | | | | | | |
| | UM-B1-PHARMA-005-M Mathematics in Life Sciences | 18 | 18 | 0 | 0 | 30 | 66 | Q2 | 3 | 3 |
| | | S-BIOG-411 - Math applied to life sciences | | | | | | | | | |
| | UM-B1-PHARMA-021-M Biochimie générale | 20 | 10 | 0 | 0 | 3 | 33 | Q2 | 3 | 3 |
| | | M-BIMO-101 - Biochimie générale | | | | | | | | | |
| | UM-B1-PHARMA-007-M Elements of Botany | 30 | 16 | 0 | 0 | 0 | 46 | Q2 | 4 | 4 |
| | | S-BIOG-402 - Elements of Botany (part A) | | | | | | | | | |
| | | M-DOYM-101 - Eléments de botanique (partie B) | | | | | | | | | |
| | UM-B1-PHARMA-009-M Introduction to Drug Treatments | 10 | 0 | 0 | 0 | 0 | 10 | Q2 | 2 | 2 |
| | | M-ANPH-101 - Introduction to the knowledge of the drug | | | | | | | | | |
| | UM-B1-PHARMA-010-M Introduction to Human Anatomy | 12 | 0 | 0 | 0 | 0 | 12 | Q2 | 2 | 2 |
| | | M-ANBC-102 - Introduction à l'anatomie humaine et à l'imagerie médicale | | | | | | | | | |
| | UM-B1-PHARMA-018-M Initiation à la recherche en sciences pharmaceutiques | 0 | 32 | 0 | 0 | 0 | 32 | Q2 | 2 | 2 |
| | | M-BHTO-106 - Initation à la recherche en sciences biomédicales et pharmaceutiques | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements transitoires 2024-2025 | | | | | | | | 0 | |
| | | | | | | | | | |
| | UM-B1-PHARMA-004-M Biomedical physics (UE transitoire) | 98 | 78 | 0 | 0 | 50 | 226 | Q1,Q2 | 14 | 14 |
| | | M-PEBI-101 - Introduction to Physics | | | | | | | | | |
| | | M-PEBI-102 - Biomedical Physics I | | | | | | | | | |
| | | M-PEBI-110 - Travaux pratiques de physique biomédicale I | | | | | | | | | |
| | | M-PEBI-105 - Biomedical Physics II | | | | | | | | | |
| | | M-PEBI-111 - Travaux pratiques de physique biomédicale II | | | | | | | | | |
| | | M-CPFA-003 - Remédiation disciplinaire aux cours introductifs en physique | | | | | | | | | |
| | | M-CPFA-020 - Remédiation disciplinaire en physique biomédicale I (partie 1) | | | | | | | | | |
| | | M-CPFA-013 - Remédiation disciplinaire en Physique biomédicale II | | | | | | | | | |
| | | M-CPFA-019 - Remédiation disciplinaire en Physique biomédicale I (partie 2) | | | | | | | | | |
| | UM-B1-PHARMA-017-M General Biochemistry (UE transitoire) | 20 | 10 | 0 | 0 | 3 | 33 | Q2 | 4 | 4 |
| | | M-BIMO-101 - Biochimie générale | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Activités d'aide à la réussite | | | | | | | | 0 | |
| | | | | | | | | | |
| | UM-B1-PHARMA-501-M Remédiation disciplinaire en biologie | 0 | 0 | 0 | 0 | 60 | 60 | Q1,Q2 | | |
| | | M-CPFA-001 - Remédiation disciplinaire en Biologie 1 | | | | | | | | | |
| | | M-CPFA-011 - Remédiation disciplinaire en Biologie 2 | | | | | | | | | |
| | UM-B1-PHARMA-502-M Remédiation disciplinaire en chimie | 0 | 0 | 0 | 0 | 60 | 60 | Q1,Q2 | | |
| | | M-CPFA-002 - Remédiation disciplinaire en Chimie générale I (Q1) | | | | | | | | | |
| | | M-CPFA-012 - Remédiation disciplinaire en Chimie organique I (Q1) | | | | | | | | | |
| | | M-CPFA-014 - Remédiation disciplinaire en Chimie générale I et II (Q2) | | | | | | | | | |
| | | M-CPFA-015 - Remédiation disciplinaire en Chimie organique I et II (Q2) | | | | | | | | | |
| | UM-B1-PHARMA-504-M Remédiation disciplinaire en physique | 0 | 0 | 0 | 0 | 50 | 50 | Q1,Q2 | | |
| | | M-CPFA-003 - Remédiation disciplinaire aux cours introductifs en physique | | | | | | | | | |
| | | M-CPFA-020 - Remédiation disciplinaire en physique biomédicale I (partie 1) | | | | | | | | | |
| | | M-CPFA-013 - Remédiation disciplinaire en Physique biomédicale II | | | | | | | | | |
| | | M-CPFA-019 - Remédiation disciplinaire en Physique biomédicale I (partie 2) | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements complémentaires pour l'étudiant qui allège son programme d'études | | | | | | | | | |
| | | | | | | | | | |
| | UM-B1-PHARMA-602-M Remises à niveau disciplinaires | 0 | 0 | 0 | 0 | 200 | 200 | Q2 | | |
| | | M-CPFA-004 - Remise à niveau disciplinaire en Biologie | | | | | | | | | |
| | | M-CPFA-005 - Remise à niveau disciplinaire en Chimie | | | | | | | | | |
| | | M-CPFA-008 - Remediation for Mathematics | | | | | | | | | |
| | | M-CPFA-006 - Remise à niveau disciplinaire en Physique | | | | | | | | | |
| | UM-B1-PHARMA-603-M Raisonnement et analyse critique de l'information | 0 | 0 | 0 | 0 | 40 | 40 | Q2 | | |
| | | M-CPFA-030 - Raisonnement et analyse critique de l'information | | | | | | | | | |
| | UM-B1-PHARMA-604-M Communication et notions d'éthique et d'empathie | 6 | 4 | 0 | 0 | 0 | 10 | Q2 | | |
| | | M-CPFA-031 - Communication et notions d'éthique et d'empathie | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |
Bloc 2 | Hours (*) | Term | Credits | Weight. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires | | | | | | | | | |
| | | | | | | | | | |
| | UM-B2-PHARMA-022-M Biochimie métabolique | 40 | 20 | 0 | 0 | 0 | 60 | Q1 | 5 | 5 |
| | | M-BIMO-207 - Biochimie métabolique | | | | | | | | | |
| | | M-BIMO-202 - Travaux pratiques en Biochimie métabolique | | | | | | | | | |
| | UM-B2-PHARMA-003-M Organic Chemistry I | 22 | 10 | 0 | 0 | 0 | 32 | Q1 | 3 | 3 |
| | | M-CGOB-201 - Chimie organique I | | | | | | | | | |
| | UM-B2-PHARMA-019-M Chimie analytique quantitative | 30 | 60 | 0 | 0 | 0 | 90 | Q1 | 8 | 8 |
| | | M-ANPH-202 - Chimie analytique quantitative | | | | | | | | | |
| | UM-B2-PHARMA-006-M Spectroscopy for Pharmaceutical and Biomedical Analysis | 20 | 30 | 0 | 0 | 0 | 50 | Q1 | 4 | 4 |
| | | M-CGOB-204 - Spectroscopy | | | | | | | | | |
| | | M-CGOB-205 - Spectroscopy exercises | | | | | | | | | |
| | UM-B2-PHARMA-007-M Eléments de physiologie générale | 18 | 8 | 0 | 0 | 0 | 26 | Q1 | 3 | 3 |
| | | M-NEUR-201 - Eléments de physiologie générale | | | | | | | | | |
| | UM-B2-PHARMA-023-M Eléments de splanchnologie | 12 | 0 | 0 | 0 | 0 | 12 | Q1 | 2 | 2 |
| | | M-ANBC-205 - splanchnologie pour les sciences biomédicales et pharmaceutiques | | | | | | | | | |
| | UM-B2-PHARMA-014-M Bibliography and IT Tools | 8 | 4 | 0 | 0 | 0 | 12 | Q1 | 2 | 2 |
| | | M-CTPH-201 - Bibliography | | | | | | | | | |
| | UM-B2-PHARMA-018-M Statistiques II | 15 | 15 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-DOYM-046 - Statistiques II | | | | | | | | | |
| | UM-B2-PHARMA-015-M English for Pharmaceutical Sciences | 48 | 0 | 0 | 0 | 0 | 48 | Q1,Q2 | 4 | 4 |
| | | V-LANG-759 - English for Pharmaceutical Sciences, part 1 | | | | | | | | | |
| | | V-LANG-760 - English for Pharmaceutical Sciences, part 2 | | | | | | | | | |
| | UM-B2-PHARMA-002-M Molecular Biology | 30 | 46 | 0 | 0 | 0 | 76 | Q2 | 6 | 6 |
| | | M-BIMO-204 - Molecular biology | | | | | | | | | |
| | | M-BIMO-205 - Travaux pratiques en Biologie moléculaire | | | | | | | | | |
| | | M-BIMO-203 - Gène, pathologie et thérapie | | | | | | | | | |
| | UM-B2-PHARMA-004-M Organic Chemistry II | 22 | 57 | 0 | 0 | 0 | 79 | Q2 | 6 | 6 |
| | | M-CGOB-202 - Chimie organique II | | | | | | | | | |
| | UM-B2-PHARMA-008-M Eléments de physiologie spéciale | 30 | 14 | 0 | 0 | 0 | 44 | Q2 | 5 | 5 |
| | | M-NEUR-203 - Eléments de physiologie spéciale : Systèmes cardiovasculaire, respiratoire, rénal et digestif et le système nerveux autonome | | | | | | | | | |
| | | M-NEUR-208 - Eléments de physiologie spéciale : Système endocrinien, y compris les systèmes génitaux | | | | | | | | | |
| | UM-B2-PHARMA-010-M Pharmacognosy I - Introduction to Pharmacognosy | 12 | 15 | 4 | 0 | 0 | 31 | Q2 | 4 | 4 |
| | | M-CTPH-021 - Pharmacognosie I - Introduction à la pharmacognosie | | | | | | | | | |
| | UM-B2-PHARMA-011-M Plant Systematics | 12 | 12 | 0 | 0 | 0 | 24 | Q2 | 3 | 3 |
| | | S-BIOG-888 - Plant Systems (part A) | | | | | | | | | |
| | | M-DOYM-028 - Systématique des plantes (partie B) | | | | | | | | | |
| | UM-B2-PHARMA-020-M Introduction à la psychologie générale | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 2 | 2 |
| | | M-DOYM-027 - Psychologie générale Introduction | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements transitoires 2024-2025 | | | | | | | | 0 | |
| | | | | | | | | | |
| | UM-B2-PHARMA-001-M Biochimie métabolique (UE transitoire) | 30 | 20 | 0 | 0 | 0 | 50 | Q1 | 5 | 5 |
| | | M-BIMO-201 - Metabolic Biochemistry | | | | | | | | | |
| | | M-BIMO-202 - Travaux pratiques en Biochimie métabolique | | | | | | | | | |
| | UM-B2-PHARMA-009-M Eléments de splanchnologie (UE transitoire) | 12 | 0 | 0 | 0 | 0 | 12 | Q1 | 3 | 3 |
| | | M-ANBC-205 - splanchnologie pour les sciences biomédicales et pharmaceutiques | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |
Bloc 3 | Hours (*) | Term | Credits | Weight. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires | | | | | | | | | |
| | | | | | | | | | |
| | UM-B3-PHARMA-018-M Pharmacochimie: études des médicaments organiques - Partie 1 | 47 | 0 | 0 | 0 | 0 | 47 | Q1 | 6 | 6 |
| | | M-CTPH-309 - Pharmacochimie - Partie 1 | | | | | | | | | |
| | UM-B3-PHARMA-006-M General Pharmacology | 18 | 10 | 0 | 0 | 0 | 28 | Q1 | 3 | 3 |
| | | M-CTPH-303 - General Pharmacology | | | | | | | | | |
| | | M-CTPH-304 - General pharmacology exercises | | | | | | | | | |
| | UM-B3-PHARMA-007-M Introduction to Cell Pharmacology | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 |
| | | M-BHTO-301 - Introduction to cellular pharmacology | | | | | | | | | |
| | UM-B3-PHARMA-009-M Immunologie | 14 | 0 | 0 | 0 | 0 | 14 | Q1 | 2 | 2 |
| | | M-DOYM-024 - Immunologie | | | | | | | | | |
| | UM-B3-PHARMA-015-M English for Pharmaceutical Sciences | 12 | 0 | 6 | 0 | 0 | 18 | Q1 | 2 | 2 |
| | | V-LANG-762 - English for Pharmaceutical Sciences, part 3 | | | | | | | | | |
| | UM-B3-PHARMA-017-M General Toxicology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-BHTO-304 - General toxicology | | | | | | | | | |
| | UM-B3-PHARMA-019-M Analyse instrumentale pharmaceutique | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-ANPH-308 - Analyse instrumentale pharmaceutique | | | | | | | | | |
| | UM-B3-PHARMA-022-M Analyse pharmaceutique appliquée | 0 | 84 | 0 | 0 | 0 | 84 | Q1 | 3 | 3 |
| | | M-ANPH-311 - Analyse pharmaceutique appliquée | | | | | | | | | |
| | UM-B3-PHARMA-023-M Principes physico-chimiques appliqués à la technologie pharmaceutique | 24 | 30 | 0 | 0 | 0 | 54 | Q1 | 5 | 5 |
| | | M-PGAL-312 - Principes physico-chimiques appliqués à la technologie pharmaceutique | | | | | | | | | |
| | UM-B3-PHARMA-010-M General and medical microbiology | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 5 | 5 |
| | | M-DOYM-014 - General and Medical Microbiology (introduction) | | | | | | | | | |
| | UM-B3-PHARMA-011-M Elements of Pathology | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 4 | 4 |
| | | M-DOYM-020 - Elements of pathology | | | | | | | | | |
| | UM-B3-PHARMA-012-M Introduction to Pharmacy Training | 0 | 15 | 80 | 0 | 0 | 95 | Q2 | 4 | 4 |
| | | M-PCLI-304 - Practical training | | | | | | | | | |
| | | M-PCLI-305 - Practical training | | | | | | | | | |
| | UM-B3-PHARMA-013-M Transdisciplinary Aspects of Pharmaceutical Thematics (CLIL course) | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 |
| | | V-LANG-761 - Transdisciplinary Aspects of Pharmaceutical Thematics(CLIL course) | | | | | | | | | |
| | UM-B3-PHARMA-020-M Etude des médicaments inorganiques | 25 | 0 | 0 | 0 | 0 | 25 | Q2 | 4 | 4 |
| | | M-ANPH-309 - Etude des médicaments inorganiques | | | | | | | | | |
| | UM-B3-PHARMA-021-M Contrôle qualité des matières premières pharmaceutiques | 5 | 80 | 0 | 0 | 0 | 85 | Q2 | 3 | 3 |
| | | M-ANPH-310 - Contrôle qualité des matières premières pharmaceutiques | | | | | | | | | |
| | UM-B3-PHARMA-024-M Pharmacognosie II: phytochimie et étude des médicaments d'origine végétale | 48 | 0 | 2 | 0 | 0 | 50 | Q2 | 6 | 6 |
| | | M-CTPH-310 - Pharmacognosie II: phytochimie et étude des médicaments d'origine végétale | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |